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INTRODUCTION
Nerve graft substitutes remain inferior to autografts for 
the repair of motor and mixed peripheral nerve injuries.1 
Nerve regeneration is a complicated process highlighted 
by Wallerian degeneration, axonal sprouting, and myelin-
ation.2 In response to injury, Schwann cells (SCs) produce 
high levels of neurotrophic growth factors.3 Successful 
crossing of a nerve gap depends on the formation of a new 
extracellular matrix (ECM) scaffold, over which blood 
vessels, fibroblasts, and SCs can migrate and regenerate 
towards the distal nerve stump.4 Acellular nerve grafts are 
rich in ECM components; however, they lack viable SCs.5 
Supplementing acellular nerve grafts with supporting cells 
may improve outcomes.6
Previously, researchers have successfully supplemented 
acellular nerve grafts with cultured SCs.7,8 However, effi-
ciently obtaining autologous SCs for clinical use is difficult 
as it requires harvest of a donor nerve and time to culture 
and proliferate.6 Adipose-derived mesenchymal stromal cells 
(MSCs) are easily accessible, rapidly expandable, capable of 
survival/integration within the host tissue and can be guided 
into non-mesenchymal lineages, such as neurons, astrocytes, 
and SC-like cells to support nerve regeneration.2,9 In vitro dif-
ferentiation is a time-consuming process and limits clinical 
applicability. Thus, application of undifferentiated MSCs, 
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Background: The purpose of this study was to evaluate the molecular mechanisms 
underlying nerve repair by a decellularized nerve allograft seeded with adipose-
derived mesenchymal stromal cells (MSCs) and compare it to the unseeded 
allograft and autograft nerve.
Methods: Undifferentiated MSCs were seeded onto decellularized nerve allografts 
and used to reconstruct a 10 mm gap in a rat sciatic nerve model. Gene expres-
sion profiles of genes essential for nerve regeneration and immunohistochemi-
cal staining (IHC) for PGP9.5, NGF, RECA-1, and S100 were obtained 2 weeks 
postoperatively.
Results: Semi-quantitative RT-PCR analysis showed that the angiogenic molecule 
VEGFA was significantly increased in seeded allografts, and transcription factor 
SOX2 was downregulated in seeded allografts. Seeded grafts showed a significant 
increase in immunohistochemical markers NGF and RECA-1, when compared 
with unseeded allografts.
Conclusions: MSCs contributed to the secretion of trophic factors. A beneficial 
effect of the MSCs on angiogenesis was found when compared with the unseeded 
nerve allograft, but implanted MSCs did not show evidence of differentiation into 
Schwann cell-like cells. (Plast Reconstr Surg Glob Open 2020;8:e2579; doi: 10.1097/
GOX.0000000000002579; Published online 21 January 2020.)
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which have been recently shown to improve nerve conduc-
tion velocity,10 is an attractive alternative.
Evaluations of nerve regeneration have relied heav-
ily on functional evaluations. Although these approaches 
have the potential to be clinically relevant, they do not 
provide insight into the mechanisms underlying the neu-
rotrophic potential of MSCs.11 Despite the popular theory 
that release of growth factors is a potential mechanism of 
the cells’ restorative capacity, quantitative analysis of neu-
rotrophic factor release from implanted MSCs is rarely 
reported12 (see figure, Supplemental Digital Content 1, 
which displays the proposed mechanism of how cell-based 
therapy can create a more favorable environment for 
peripheral nerve regeneration is depicted, http://links.
lww.com/PRSGO/B268).
Questions regarding cell fate and differentiation 
remain unanswered. The purpose of this study was to eval-
uate the molecular mechanisms underlying nerve repair 
with a decellularized nerve allograft seeded with isogenic, 
undifferentiated, adipose-derived MSCs.
MATERIALS AND METHODS
After IACUC institutional review committee approval, 
isogenic Lewis rat MSCs were dynamically seeded onto 
Sprague Dawley rat decellularized nerve allografts (N = 9) 
and used to bridge a 10-mm sciatic nerve defect in Lewis 
rats. Sprague-Dawley rats were chosen as nerve donors, as 
there is a major histocompatibility mismatch to the recipient 
Lewis rat.13 This mismatch would mimic the human clinical 
situation. The fate of implanted MSCs was determined by 
evaluating gene expression profiles 2 weeks postoperatively. 
IHC staining was obtained for neurite outgrowth, angiogen-
esis, and SCs to determine whether up or downregulation 
of growth factor levels had functional consequences for 
early nerve regeneration. Outcomes were compared with 
unseeded allografts (N = 9) and autograft controls (N = 9).
Isolation of Rat MSCs
MSCs were obtained from the inguinal fat pad of inbred 
Lewis rats, as previously described by Kingham et al.14 Cultures 
were maintained at subconfluent levels in a 37°C incuba-
tor with 5% CO2 and passaged with TrypLE (Invitrogen). 
MSCs were then lentivirally transduced to express the firefly 
luciferase, as previously described.15 This method has been 
shown to display no differences in viability and cell prolif-
eration between labeled/unlabeled cells and luciferase was 
expressed steadily in vitro. All MSCs used in the experiment 
were of passage 5 and have previously been shown to be capa-
ble of multilineage differentiation.15 Undifferentiated MSCs 
were used as they have been shown respond to the demands 
placed on them by the local environment.
Preparation of Allografts
A total of 18 rat sciatic nerve segments of 1.5 cm were 
harvested from Sprague-Dawley rats, weighing 250–350 g 
(Harlan, Indianapolis, Ind.). Sciatic nerves were asepti-
cally excised, cleared of peripheral fat tissue, and decel-
lularized using the protocol utilizing elastase as previously 
described.16 Before surgery, 9 decellularized allografts 
were dynamically seeded with passage 5 Lewis rat MSCs as 
previously described.17 Nerve allografts were combined with 
MSCs in a 15-ml TubeSpin Bioreactor tube containing 10-ml 
cell culture medium and 1 million cells per nerve. After 12 
hours of incubation, seeded nerves were used for surgery.
Surgical Procedure
Lewis rats (N = 27) weighing 250–350 g (Harlan) were 
anesthesized and surgical procedures were performed 
under standard aseptic conditions, as previously described 
by Hundepool et al.18 All allografts were cut to 10 mm. 
In group I, seeded allografts (N = 9) were used to bridge 
the 10-mm nerve gap using 10-0 nylon epineural sutures 
(Ethicon, Inc., Somerville, N.J.). In group II, acellular 
allografts (N = 9) were used. In the control group III, autol-
ogous nerve segments were reversed and sutured back.
Outcome Measurements
Two weeks postoperatively, anesthesia was induced 
using isoflurane and all animals (N = 27) were sacrificed 
with an intraperitoneal overdose of Fatal-Plus (Vortech 
Pharmaceuticals, Dearborn, Mich.).
Quantitative Real-time Reverse-transcriptase Polymerase 
Chain Reaction
Changes in relative gene expression profiles of MSCs 
seeded allografts were evaluated by quantitative real-time 
reverse-transcriptase polymerase chain reaction and com-
pared with unseeded allografts and autograft controls (N 
= 5 per group). Nerve segments were harvested, frozen in 
QIAzol Lysis Reagent (Qiagen, Valencia, Calif.) and stored 
at −80°C. Total RNA was extracted using the miRNeasy 
Mini Kit (Qiagen) and RNA yield was evaluated using a 
Nanodrop 2000 (Thermo Scientific, Inc., Waltham, Mass.) 
followed by reverse transcription into cDNA by RT-PCR 
using SuperScript III (Invitrogen). Resulting cDNA libraries 
were analyzed by quantitative real-time reverse-transcriptase 
polymerase chain reaction (C1000 Touch Thermalk Cycler, 
BioRad, Hercules, Calif.) using SYBR Green detection with 
specific primers, chosen from the literature, for a panel of 
genes essential for nerve regeneration (Table 1). Results were 
analyzed to map MSC characteristics including proliferation, 
apoptosis, myelination, and ECM-production.8,19,21 Samples 
were analyzed in triplicate and results were normalized to 
the reference housekeeping gene GAPDH within each sam-
ple and then normalized to the unseeded allograft group. 
Differences in gene expression levels were quantified using 
the comparative delta crossover threshold [2(−ΔΔCt)] method.22
Immunohistochemical Staining
Sciatic nerves (N = 4) of the operated sites were 
explanted over a length from 5 mm proximal and distal 
to the graft, fixed in 4% Paraformaldehyde (Sigma), sus-
pended in Tissue-Tek OCT Compound, and snap frozen. 
Transverse sections (5-μm thick) were cut on a cryostat at 
different levels within the middle of the repair site (see 
figure, Supplemental Digital Content 2, which displays 
transverse sections were cut on a cryostat at different lev-
els within the middle of the nerve, http://links.lww.com/
PRSGO/B269).
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IHC staining was obtained for PGP9.5, NGF, RECA-1, and 
S100. Luciferase labeled MSCs were also double stained for 
Luciferase and S100 to study MSC differentiation to SC like 
cells. Slides were stored at −80°C and before staining dried for 
2 hours. Slides were manually post fixed and retrieved online 
using Epitope Retrieval 1 (Leica Microsystems). Sections were 
incubated for 60 minutes at 24°C in the following primary 
antibodies: polyclonal S100 anti-rabbit (Dako Z0311) was 
used at 1:5,000; polyclonal PGP9.5 anti-rabbit (Dako Z5116) 
was used at 1:500; monoclonal RECA-1 anti–mouse (Abcam 
ab9774) was used at 1:200; monoclonal NGF anti-rabbit 
(Abcam ab52918) was used at 1:150 and polyclonal anti-rab-
bit Firefly Luciferase (Abcam ab21176) was used at 1:2,000. 
Sections were then washed with PBS and incubated with sec-
ondary antibodies [Alexa Fluor 568 or 488 Goat-anti-Rabbit 
(Invitrogen) at 24°C for 60 minutes]. The Research Detection 
System (Leica DS9455) was used and included Rodent Block 
R (Biocare RBR962). Cell nuclei were stained with Hoechst 
33342 (Invitrogen H1399). Once completed, slides were 
rinsed in distilled water, coverslipped, and observed by a 
confocal microscope (LSM 780, Zeiss). Nerve areas were cap-
tured at ×10 (tile-scan) and ×20 magnification.
Image Analysis
Fluorescence intensity in the nerve cross-sections was 
measured using ImageJ (NIH, Bethesda, MD) to quantify 
differences between the grafts. All images were obtained 
with the same settings and analysis was performed on the 
antibody monolayer, without Hoechst. A representative 
area was selected and the integrated density was measured. 
To determine and correct for the background signal, 3 
areas of the image that had no fluorescence were selected 
and mean gray value was measured. Results were used to 
calculate the corrected total cell fluorescence (CTCF).23
Statistical Analysis
The Kolmogorov-Smirnoff test was applied to test for a 
normal distribution. To detect differences between groups, 
data were analyzed using the Kruskal-Wallis test followed by 
the Dunn-Bonferroni post hoc test. Statistically significance 
was set at P < 0.05. All results are reported as mean ± SD.
RESULTS
Quantitative Real-time Reverse-transcriptase Polymerase 
Chain Reaction
All animals survived and there were no surgical com-
plications. Supplemental  Figure 3a–d demonstrates the 
expression levels clustered by genes sharing a common 
function. NGF, GDNF, PTN, and GAP43 were chosen as rep-
resentative neurotrophic factors as they have been shown 
to promote neuronal survival and axonal regeneration 
after peripheral nerve injury11 [see figure, Supplemental 
Digital Content 3, which displays relative gene expression 
14 days postoperatively. A, NGF, GDNF, PTN, and GAP43 
mRNA expression levels were measured in the autograft, 
allograft, and MSC seeded nerve allograft (n = 5). Relative 
expression levels are shown with regard to the allograft 
(value = 1) *P < 0.05. B, VEGFA, CD31, MPZ, PMP22, and 
MBP mRNA expression levels were measured. Relative 
expression levels are shown with regard to the allograft 
(value = 1) *P < 0.05. C, COL1A1, COL3A1, LAMB2, and 
FBLN1 mRNA expression levels were measured. Relative 
expression levels are shown with regard to the allograft 
(value = 1). D, CASP3, EGR1, SOX2, CCNB2, and FABP4 
mRNA expression levels were measured. Relative expres-
sion levels are shown with regard to the allograft (value = 
1), http://links.lww.com/PRSGO/B270].
Analysis showed significantly higher NGF mRNA levels 
after autograft reconstruction when compared with the 
unseeded allograft (2.3-fold increase, P = 0.047) or the 
seeded nerve allograft (2.6-fold increase P = 0.038). There 
was no significant difference between the allograft groups 
(P = 0.863). For the expression of GDNF, PTN, and GAP43, 
no significant differences were found between the groups 
(P = 0.849, 0.344, 0.557).
Table 1. mRNA Primer Sequences
Gene ID Biology Forward Privmer Reverse Primer
GAPDH Reference gene TACCAGGGCTGCCTTCTCTTG GGATCTCGCTCCTGGAAGATG
NGF Neurotrophic marker CACTCTGAGGTGCATAGCGT CTATTGGTTCAGCAGGGGCA
GDNF Neurotrophic marker CGCTGACCAGTGACTCCAATA GCGACCTTTCCCTCTGGAAT
PTN Neurotrophic marker GCCGAGTGCAAACAAACCAT TGATTCCGCTTGAGGCTTGG
GAP43 Cytoplasmic protein GATAACTCGCCGTCCTCCAA CTACAGCTTCTTTCTCCTCCTCA
VEGFA Angiogenic marker CAGAAAGCCCATGAAGTGGTG CTTCATCATTGCAGCAGCCC
PECAM1/CD31 Angiogenic marker TTGTGACCAGTCTCCGAAGC TGGCTGTTGGTTTCCACACT
MPZ Myelination marker AGGCCGAGATGCCATTTCAA CCCATACCTAGTGGGCACTTTT
PMP22 Myelination marker GTCTGGTCTGCTGTGAGCAT GCCATTGGCTGACGATGGTG
MBP Myelination marker TCTGGCAAGGACTCACACAC AAATCTGCTGAGGGACAGGC
COL1A1 ECM protein AAGTCTCAAGATGGTGGCCG TCGATCCAGTACTCTCCGCT
COL3A1 ECM protein CCCGGCAACAATGGTAATCC GACCTCGTGCTCCAGTTAGC
LAMB2 ECM protein AGTACCCACACGGATGGAGTG CTCGAGAACAGCCAGGTACA
FBLN1 ECM protein GCAGACACCTTTCGCCAAGA CGTGACAGCCCTCAGAAAGA
CASP3 Apoptosis protein GGAGCTTGGAACGCGAAGAA ACACAAGCCCATTTCAGGGT
EGR1 Transcription factor CACCTGACCACAGAGTCCTTTT GTTGGAGGGTTGGTCATGCT
SOX2 Transcription factor AGTGGTACGTTAGGCGCTTC CCCAGCAAGAACCCTTTCCT
CCNB2 Protein coding gene ACCAGTGCAGATGGAGACAC GACTGCAAAGCCTCAAGCTG
FABP4 Protein coding gene TGAAAGAAGTGGGAGTTGGCTT TGGTCGACTTTCCATCCCAC
Sequences for primers used in qPCR reactions (ECM). The following genes were analyzed: glyceraldehyde 3-phosphate dehydrogenase (GAPDH), nerve growth 
factor (NGF), glial cell line-derived neurotrophic factor (GDNF), pleiotrophin (PTN), growth associated protein 43 (GAP43), vascular endothelial cell growth 
factor alpha (VEGFA), platelet endothelial cell adhesion molecule 1 (PECAM1/CD31), myelin protein zero (MPZ), peripheral myelin protein 22 (PMP22), myelin 
basic protein (MBP), collagen type 1 (COL1A1) and 3 (COL3A1), laminin subunit beta 2 (LAMB2), fibulin 1 (FBLN1), caspase 3 (CASP3), early growth response 
protein (EGR1), sex determining region y-box 2 (SOX2), cyclin B2 (CCNB2), and fatty acid binding protein 4 (FABP4).
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Gene expression for the angiogenic molecule VEGFA, 
endothelial marker CD31 and myelination factors MPZ, 
PMP22, and MBP is depicted in figure, Supplemental 
Digital Content 3b, http://links.lww.com/PRSGO/
B270. Analysis showed a significant 4.5-fold increase 
of VEGFA expression in seeded nerve allografts (P = 
0.009) and a significant 3.2-fold increase in autografts 
(P = 0.014) when compared with the unseeded nerve 
A
B
Fig. 1. a, pGp9.5 expression. Sections at the mid-graft stained with the (sensory) axonal marker pGp9.5 showed axons in the autograft, allograft 
and mSC seeded nerve allograft. representative images are depicted with the double layer (Dapi). magnification ×10. Scale bar reflects 5 mm. 
n = 4 animals per group. B, pGp9.5 staining intensity quantification. Quantitative analysis of pGp9.5 staining by calculating and comparing 
the average CtCF-score among groups. images were analyzed without Dapi. no significant differences were found. n = 4 animals per group.
A
B
Fig. 2. a, nGF expression. Sections at the mid-graft stained for nGF showed presence of the marker in the autograft, allograft, and mSC 
seeded nerve allograft. representative images are depicted with the double layer (Dapi). magnification ×10. Scale bar reflects 5 mm. n = 4 
animals per group. B, nGF staining intensity quantification. Quantitative analysis of nGF staining by calculating and comparing the aver-
age CtCF-score among groups. images were analyzed without Dapi. a significant increase of nGF expression in the autograft and mSC 
seeded allograft was found when compared with the unseeded nerve allograft. n = 4 animals per group (*P < 0.05).
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A
B
Fig. 3. a, rECa-1 expression. Sections at the mid-graft stained for endothelial marker rECa-1 showed presence of the marker in the 
autograft, allograft, and mSC seeded nerve allograft. representative images are depicted with the double layer (Dapi). magnification ×10. 
Scale bar reflects 5 mm. n = 4 animals per group. B, rECa-1 staining intensity quantification. Quantitative analysis of rECa-1 staining by 
calculating and comparing the average CtCF-score among groups. images were analyzed without Dapi. a significant increase of rECa-1 
expression in the autograft and mSC seeded allograft was found when compared with the unseeded nerve allograft. n = 4 animals per 
group (*P < 0.05).
A
B
Fig. 4. a, S100 expression. Sections at the mid-graft stained for SC marker S100 showed presence of the marker in the autograft, allograft, and 
mSC seeded nerve allograft. representative images are depicted with the double layer (Dapi). magnification ×10. Scale bar reflects 5 mm. 
n = 4 animals per group. B, S100 staining intensity quantification. Quantitative analysis of S100 staining by calculating and comparing the 
average CtCF-score among groups. images were analyzed without Dapi. no significant differences were found. n = 4 animals per group.
PRS Global Open • 2020
6
allografts. For CD31, an increasing trend (1.2-fold) was 
observed as well in the seeded allograft group; however, 
differences were not significant (P = 0.616). Myelination 
markers MPZ, PMP22, and MBP, required for formation 
and maintenance of myelin, were all equally expressed.
ECM-related markers COL1A1 and COL3A1 were 
highly expressed in all groups and no significant differ-
ences were found. The LAMB2 and FBLN1 genes play 
a role in cell adhesion, differentiation, and migration. 
Expression was moderate in all groups and differences 
Fig. 5. luciferase and S100 double stain. Sections at the mid-graft of mSC seeded nerve allografts have been stained for anti-luciferase 
(red) and SC marker S100 (green). Cell nuclei were stained by Dapi (blue). Overlapping images are shown in the right column. many 
luciferase positive cells are negative for S100, indicating that the implanted cells did not differentiate into a SC phenotype. magnification 
×20. Scale bar reflects 100 μm. n = 4 animals.
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were non-significant (see figure, Supplemental Digital 
Content 3c, http://links.lww.com/PRSGO/B270).24
Additional genes (see figure, Supplemental Digital 
Content 3d, http://links.lww.com/PRSGO/B270) were 
evaluated to map MSC characteristics including prolifera-
tion and apoptosis. A non-significant increase (2.2-fold) in 
CASP3 in MSC seeded allografts when compared with the 
autograft and unseeded allograft was found. For EGR1, no 
significant differences were found. The SOX2 gene mRNA 
level was significantly downregulated (0.3-fold, P = 0.006) 
in MSC seeded allografts. No significant differences were 
found for CCNB2 and FABP4.
Immunohistochemical Staining
PGP9.5 was assessed to quantify the amount of newly 
formed (sensory) axons. The marker was present in all 3 
groups and representative images are depicted in Fig. 1A. The 
CTCF score in the nerve autograft (95.2 ± 30.9) was increased 
when compared with the unseeded allograft (33.4 ± 6.8) and 
MSC seeded allograft (60.6 ± 36.9), respectively. The MSC 
seeded graft showed an increased expression but not signifi-
cant when compared with the unseeded allograft (Fig. 1B).
NGF is critical in regeneration, survival, and mainte-
nance of neurons and is expressed during early neural 
development.25 NGF was relatively highly expressed in all 
3 groups (Fig. 2A). Both the CTCF score of the nerve auto-
graft (245.2 ± 79.8) and the MSC seeded allograft (175.9 
± 16.1) were significantly increased (P = 0.007 and P = 
0.018) when compared with the unseeded allograft (122.6 
± 40.1). There were no significant differences between the 
autograft and seeded allograft (Fig. 2B).
RECA-1 is expressed in rat endothelial cells and was used 
to study angiogenesis.25 RECA-1 was highly expressed in the 
autograft and MSC seeded allograft group (Fig. 3A). Both the 
CTCF score of the nerve autograft (282.6 ± 91.9) and the MSC 
seeded allograft (187.5 ± 26.5) were significantly increased (P 
= 0.007 and P = 0.018) when compared with the unseeded 
allograft (48.4 ± 36.5). There were no significant differences 
between the autograft and seeded allograft (Fig. 3B).
S100 was measured to assess the amount of SC-like cells. 
The marker was highly expressed in all groups and repre-
sentative images are depicted in Fig. 4A. Quantification of 
the expression showed no significant differences between 
groups in CTCF score for the nerve autograft (342.8 ± 
82.6), unseeded allograft (245.9 ± 71.6), and MSC seeded 
allograft (263.7 ± 93.3), respectively (Fig. 4B).
Luciferase-labeled MSCs were double stained for 
Luciferase and S100 to study MSC differentiation to 
SC-like cells. Luciferase-positive cells were detected in 
high abundance in the peripheral areas of the nerve graft, 
but only a few showed co-staining with S100. Many lucif-
erase-positive cells were negative for S100, indicating that 
the implanted cells did not differentiate in large numbers 
into SC-like cells (Fig. 5).
DISCUSSION
We report on early regenerative parameters following 
nerve repair by a decellularized nerve allograft pre-seeded 
with adipose-derived MSCs and compare it to the unseeded 
allograft and autograft nerve.
NGF is important for the development and mainte-
nance of the sympathetic and sensory nervous systems.11 
NGF gene-expression was significantly increased in auto-
grafts, which correlates with the increasing trend in NGF 
staining intensity. However, in seeded allografts, NGF 
staining intensity was significantly increased when com-
pared with unseeded allografts, suggesting that MSC 
seeded nerve allografts support the regeneration of 
sensory nerves to a greater extent than unseeded nerve 
allografts. NGF is not expressed by motor neurons, is 
barely detectable in healthy sciatic nerves, and, following 
nerve injury, it shows a biphasic upregulation in the distal 
nerve stump during the first week of regeneration.11 NGF 
mRNA decrease can be explained by either the motor 
origin of the nerve allografts, or the solitary 2-week time 
point. It is possible that in both allograft groups, levels 
were increased in the first week and were already normal-
ized at week 2.
Both the VEGFA-gene and CD31 are involved in angio-
genesis and endothelial cell growth. VEGFA plays a role 
in wound healing, can promote neovascularization, and 
has a neurotrophic effect in enhancing the survival of SCs 
and protecting neurons from ischemic injury.26 VEGFA 
molecule was significantly increased in seeded allografts 
and CD31 showed the same increasing trend. This corre-
lates with the significantly increased RECA-1 intensity in 
seeded nerve grafts; however, the intensity was also sig-
nificantly increased in autografts. Previous studies have 
reported beneficial effects of VEGFA on vascularization, 
resulting in improved regeneration in acellular grafts.27 
Kingham et al28 showed that in addition to acting directly 
on the nervous system, (differentiated) MSCs were able to 
boost vascularization at the area of nerve injury. Similar 
to our results, the authors showed an increased VEGFA 
secretion and RECA-1 staining intensity. Other studies 
have confirmed the correlation between increased vascu-
larization and enhanced nerve regeneration within acel-
lular conduits.29,30
CASP3 was measured to assess the potential of seeded 
MSCs to mediate cell apoptosis. We hypothesized that 
MSCs would reduce apoptosis, but the increase in seeded 
allografts suggests that a portion of the cells go into apop-
tosis. We previously showed that implanted undifferenti-
ated MSCs do not survive longer than 4 weeks and that the 
number of cells gradually diminishes over time.15 Kingham 
et al28 showed that CASP3 levels were significantly reduced 
when nerve conduits were filled with stimulated cells, 
while unstimulated MSCs had no significant effect. This 
could suggest that differentiated cells survive longer than 
undifferentiated cells.
The SOX2 gene is a key transcription factor in the 
regulation of pluripotency and neural differentiation. 
Cells expressing SOX2 are capable of proliferating and 
producing differentiated neural cell types.31 Transcription 
factor SOX2 was significantly downregulated in seeded 
allografts, suggesting that after 2 weeks, seeded MSCs no 
longer proliferate and may have reached a differentiated 
state. MSCs may not have differentiated into SC-like cells 
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as there was no increase in myelination markers and only 
a moderate increase in S100 staining intensity. This is in 
line with previous reports that found no histological evi-
dence of MSC transdifferentiation into SC-like cells within 
14-days follow-up.32,33 Others concluded that the therapeu-
tic effect was maintained for several weeks after there were 
no significant quantities of viable cells and concluded that 
the regenerative effect of MSCs was mediated by an initial 
boost of released growth factors or by an indirect effect on 
endogenous SC activity.2,34 In line with these results, Wang 
et al35 detected only few S100 positive cells after implant-
ing MSCs in an acellular nerve allograft.
The anti-luciferase and S100 double stain confirmed 
that implanted cells did not differentiate in large num-
bers into a SC phenotype. This is consistent with previ-
ous reports, concluding that adipose-derived MSCs do 
not differentiate into SCs but probably secrete some type 
of humoral factor or VEGFA that promotes the prolifera-
tion or migration of SCs.36 Sowa et al37 also concluded that 
undifferentiated implanted adipose-derived MSCs did not 
differentiate into SC but do promote peripheral nerve 
regeneration at the injured site.
In vitro, it has been shown that the cues of the ECM 
increased neurotrophic gene expression.24 In vivo, undif-
ferentiated cells may undergo differentiation in response 
to local stimuli. The hypoxic milieu of the wound might 
have triggered the MSCs to produce angiogenic molecules; 
which could be the underlying mechanism of MSCs restor-
ative capacity. Wang et al38 concluded that in vivo differ-
entiation was safer, site-dependent, and entirely under the 
control of signals from the endogenous microenvironment.
Undifferentiated MSCs can potentially differentiate 
into unwanted cell types or form teratomas; however, 
this risk is very low. Because undifferentiated MSCs only 
develop into cells of mesodermal lineages, while the com-
position of teratoma requires all 3 germ cell layers.39 Klein 
et al10 reported there is controversy regarding whether this 
risk of malignant transformation is evident for adipose-
derived MSCs and reported no tumor formations in their 
study. Nonetheless, for future clinical implementation this 
potential risk has to be investigated.
Strengths of this study include the use of a non-dam-
aging cell seeding technique and a design that mimics the 
human situation with major histocompatibility complex 
mismatched allograft donors and recipients.
We recognize the limitations of this study. Successful 
axonal regeneration depends on a dynamic balance 
between growth factors and analysis of multiple time 
points would provide more insight. No functional mea-
surements were performed because 2 weeks is too early 
for any motor reinnervation to occur. Future studies 
should focus on the growth factor expression at mul-
tiple time-points and should determine if the initially 
improved regenerative response of MSCs enhanced 
decellularized nerve allografts results in enhanced func-
tional recovery.
CONCLUSIONS
We aimed to evaluate the molecular mechanisms 
underlying nerve repair by a decellularized nerve allograft 
seeded with undifferentiated MSCs. We confirmed that 
MSCs contribute to the secretion of trophic factors, result-
ing in a beneficial effect of the MSCs on angiogenesis. 
Implanted MSCs did not show evidence of differentiation 
into SC-like cells.
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